Pressure grows on NHS to stump up for £60,000 'miracle' dementia drugs as drug watchdog reopens talks to give it the green light
Lecanemab and donanemab were hailed as 'the beginning of the end' of dementia last year, after studies showed they both slowed the progression of the memory-robbing illness.